Home LiteratureArticle Details
PMID: 26275405 Published · epublish English Comparative Study Journal Article Research Support, Non-U.S. Gov't

Comparison of different approaches to estimating age standardized net survival.

BMC medical research methodology ·Vol. 15 ·2015-08-15 ·Pages 64

Lambert PC, Dickman PW, Rutherford MJ

Abstract

Age-standardized net survival provides an important population-based summary of cancer survival that appropriately accounts for differences in other-cause mortality rates and standardizes the population age distribution to allow fair comparisons. Recently, there has been debate over the most appropriate method for estimating this quantity, with the traditional Ederer II approach being shown to have potential bias. We compare lifetable-based estimates (Ederer II), a new unbiased method based on inverse probability of censoring weights (Pohar Perme) and model-based estimates. We make the comparison in a simulation setting; generating scenarios where we would expect to see a large theoretical bias. Our simulations demonstrate that even in relatively extreme scenarios there is negligible bias in age-standardized net survival when using the age-standardized Ederer II method, modelling with continuous age or using the Pohar Perme method. However, both the Ederer II and modelling approaches have some advantages over the Pohar Perme method in terms of greater precision, particularly for longer-term follow-up (10 and 15 years). Our results show that, when age-standardizing, concern over bias with the traditional methods is unfounded. We have also shown advantages in using the more traditional and modelling methods.

MeSH Terms
Adolescent Adult Age Distribution Age Factors Aged Aged, 80 and over Algorithms Child Child, Preschool Computer Simulation Humans Infant Infant, Newborn Middle Aged Models, Theoretical Neoplasms/mortality Registries/statistics & numerical data Survival Analysis Survival Rate
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Lambert Paul C
Department of Health Sciences, University of Leicester, University Road, Leicester, LE1 7RH, UK. [email protected]. | Department of Medical Epidemiology and Biostatistics, Karolinska Insitutet, Stockholm, PO BOX 281, 24105, Sweden. [email protected].
Dickman Paul W
Department of Medical Epidemiology and Biostatistics, Karolinska Insitutet, Stockholm, PO BOX 281, 24105, Sweden. [email protected].
Rutherford Mark J
Department of Health Sciences, University of Leicester, University Road, Leicester, LE1 7RH, UK. [email protected].
References (29)
29 references, click to expand
  1. Cumulative cause-specific mortality for cancer patients in the presence of other causes: a crude analogue of relative survival.
    Stat Med. 2000 Jul 15;19(13):1729-40 PMID: 10861774
  2. Standard cancer patient population for age standardising survival ratios.
    Eur J Cancer. 2004 Oct;40(15):2307-16 PMID: 15454257
  3. Choosing the net survival method for cancer survival estimation.
    Eur J Cancer. 2015 Jun;51(9):1123-9 PMID: 24183462
  4. Simulating biologically plausible complex survival data.
    Stat Med. 2013 Oct 15;32(23):4118-34 PMID: 23613458
  5. Informative censoring in relative survival.
    Stat Med. 2013 Nov 30;32(27):4791-802 PMID: 23761182
  6. Estimating net survival in population-based cancer studies.
    Int J Cancer. 2013 Jul 15;133(2):519-21 PMID: 23338817
  7. Cancer net survival on registry data: use of the new unbiased Pohar-Perme estimator and magnitude of the bias with the classical methods.
    Int J Cancer. 2013 May 15;132(10):2359-69 PMID: 22961565
  8. Avoidable deaths and random variation in patients' survival.
    Br J Cancer. 2012 May 22;106(11):1846-9 PMID: 22531640
  9. On estimation in relative survival.
    Biometrics. 2012 Mar;68(1):113-20 PMID: 21689081
  10. Estimating net survival: the importance of allowing for informative censoring.
    Stat Med. 2012 Apr 13;31(8):775-86 PMID: 22281942
  11. A comparison of prostate cancer survival in England, Norway and Sweden: a population-based study.
    Cancer Epidemiol. 2012 Feb;36(1):e7-12 PMID: 21907655
  12. Comparison of methods for calculating relative survival in population-based studies.
    Cancer Epidemiol. 2012 Feb;36(1):16-21 PMID: 21840284
  13. How many deaths would be avoidable if socioeconomic inequalities in cancer survival in England were eliminated? A national population-based study, 1996-2006.
    Eur J Cancer. 2012 Jan;48(2):270-8 PMID: 22093945
  14. Quantifying differences in breast cancer survival between England and Norway.
    Cancer Epidemiol. 2011 Dec;35(6):526-33 PMID: 21606014
  15. Choosing the relative survival method for cancer survival estimation.
    Eur J Cancer. 2011 Sep;47(14):2202-10 PMID: 21549589
  16. A population-based comparison of the survival of patients with colorectal cancer in England, Norway and Sweden between 1996 and 2004.
    Gut. 2011 Aug;60(8):1087-93 PMID: 21303917
  17. Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995-2007 (the International Cancer Benchmarking Partnership): an analysis of population-based cancer registry data.
    Lancet. 2011 Jan 8;377(9760):127-38 PMID: 21183212
  18. Breast cancer survival in England, Norway and Sweden: a population-based comparison.
    Int J Cancer. 2010 Dec 1;127(11):2630-8 PMID: 20162669
  19. National comparisons of lung cancer survival in England, Norway and Sweden 2001-2004: differences occur early in follow-up.
    Thorax. 2010 May;65(5):436-41 PMID: 20435867
  20. Estimating the crude probability of death due to cancer and other causes using relative survival models.
    Stat Med. 2010 Mar 30;29(7-8):885-95 PMID: 20213719
  21. Improved patient survival for acute myeloid leukemia: a population-based study of 9729 patients diagnosed in Sweden between 1973 and 2005.
    Blood. 2009 Apr 16;113(16):3666-72 PMID: 19020306
  22. EUROCARE-4. Survival of cancer patients diagnosed in 1995-1999. Results and commentary.
    Eur J Cancer. 2009 Apr;45(6):931-91 PMID: 19171476
  23. Cancer survival in five continents: a worldwide population-based study (CONCORD).
    Lancet Oncol. 2008 Aug;9(8):730-56 PMID: 18639491
  24. Flexible parametric models for relative survival, with application in coronary heart disease.
    Stat Med. 2007 Dec 30;26(30):5486-98 PMID: 17893893
  25. The design of simulation studies in medical statistics.
    Stat Med. 2006 Dec 30;25(24):4279-92 PMID: 16947139
  26. Dichotomizing continuous predictors in multiple regression: a bad idea.
    Stat Med. 2006 Jan 15;25(1):127-41 PMID: 16217841
  27. Cancer survival corrected for heterogeneity in patient withdrawal.
    Biometrics. 1982 Dec;38(4):933-42 PMID: 7168796
  28. An alternative approach to age adjustment of cancer survival rates.
    Eur J Cancer. 2004 Oct;40(15):2317-22 PMID: 15454258
  29. Regression models for relative survival.
    Stat Med. 2004 Jan 15;23(1):51-64 PMID: 14695639
Article Info
Journal
BMC medical research methodology
Abbr.
BMC Med Res Methodol
ISSN
1471-2288
Published
2015-08-15
Epub
2015-00-15
Pages
64
Language
English
Region
England
NLM ID
100968545
PMCID
PMC4537569
Subset
IM
Grants
Cancer Research UK · 13275 · United Kingdom
Cancer Research UK · CRUK_A1327 · United Kingdom
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]